Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 3
2012 2
2013 2
2014 3
2015 6
2016 9
2017 6
2018 15
2019 10
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean yuzhong chen (35 results)?
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
Wan Y, Shang J, Sun S, Tai W, Chen J, Geng Q, He L, Chen Y, Wu J, Shi Z, Zhou Y, Du L, Li F. Wan Y, et al. Among authors: chen y. J Virol. 2020 Feb 14;94(5):e02015-19. doi: 10.1128/JVI.02015-19. Print 2020 Feb 14. J Virol. 2020. PMID: 31826992 Free PMC article.
Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV.
Jiang Y, Zhao G, Song N, Li P, Chen Y, Guo Y, Li J, Du L, Jiang S, Guo R, Sun S, Zhou Y. Jiang Y, et al. Among authors: chen y. Emerg Microbes Infect. 2018 Apr 24;7(1):77. doi: 10.1038/s41426-018-0063-8. Emerg Microbes Infect. 2018. PMID: 29691378 Free PMC article.
Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV.
Jiang Y, Li J, Teng Y, Sun H, Tian G, He L, Li P, Chen Y, Guo Y, Li J, Zhao G, Zhou Y, Sun S. Jiang Y, et al. Among authors: chen y. Viruses. 2019 Jan 9;11(1):39. doi: 10.3390/v11010039. Viruses. 2019. PMID: 30634407 Free PMC article.
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G, He L, Sun S, Qiu H, Tai W, Chen J, Li J, Chen Y, Guo Y, Wang Y, Shang J, Ji K, Fan R, Du E, Jiang S, Li F, Du L, Zhou Y. Zhao G, et al. Among authors: chen y. J Virol. 2018 Aug 29;92(18):e00837-18. doi: 10.1128/JVI.00837-18. Print 2018 Sep 15. J Virol. 2018. PMID: 29950421 Free PMC article.
Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis.
Liu R, Chen Y, Fu W, Wang S, Cui Y, Zhao X, Lei ZN, Hettinghouse A, Liu J, Wang C, Zhang C, Bi Y, Xiao G, Chen ZS, Liu CJ. Liu R, et al. Among authors: chen y. Ann Rheum Dis. 2019 Nov;78(11):1524-1535. doi: 10.1136/annrheumdis-2019-215543. Epub 2019 Jul 13. Ann Rheum Dis. 2019. PMID: 31302596
Molecular regulations and therapeutic targets of Gaucher disease.
Chen Y, Sud N, Hettinghouse A, Liu CJ. Chen Y, et al. Cytokine Growth Factor Rev. 2018 Jun;41:65-74. doi: 10.1016/j.cytogfr.2018.04.003. Epub 2018 Apr 11. Cytokine Growth Factor Rev. 2018. PMID: 29699937 Review.
Treatment for lupus nephritis: an overview of systematic reviews and meta-analyses.
Chen Y, Sun J, Zou K, Yang Y, Liu G. Chen Y, et al. Rheumatol Int. 2017 Jul;37(7):1089-1099. doi: 10.1007/s00296-017-3733-2. Epub 2017 May 10. Rheumatol Int. 2017. PMID: 28493175 Review.
Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases.
Chen Y, Sun J, Liu H, Yin G, Xie Q. Chen Y, et al. J Immunol Res. 2019 Dec 31;2019:5727516. doi: 10.1155/2019/5727516. eCollection 2019. J Immunol Res. 2019. PMID: 32083141 Free PMC article. Review.
Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain.
He L, Tai W, Li J, Chen Y, Gao Y, Li J, Sun S, Zhou Y, Du L, Zhao G. He L, et al. Among authors: chen y. Viruses. 2019 Feb 19;11(2):166. doi: 10.3390/v11020166. Viruses. 2019. PMID: 30791410 Free PMC article.
52 results
Jump to page